References
- Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., … Taylor, D. (2010). Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women, Science, 329(5996), 1168–1174. doi:10.1126/science.1193748
- Abdool Karim, Q., Leask, K., Kharsany, A., Humphries, H., Ntombela, F., Samsunder, N., … Abdool Karim, S. (2015). Impact of conditional cash incentives on HSV-2 and HIV in rural high school students in South Africa. CAPRISA 007 matched-pair cluster randomized controlled trial. Abstract. Eighth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver. Retrieved from http://pag.ias2015.org/Search/Index
- Adam, P. C., de Wit, J. B., Toskin, I., Mathers, B. M., Nashkhoev, M., Zablotska, I., … Rugg, D. (2009). Estimating levels of HIV testing, HIV prevention coverage, HIV knowledge, and condom use among men who have sex with men (MSM) in low-income and middle-income countries. Journal of Acquired Immune Deficiency Syndromes, 52(Suppl. 2), S143–S151. doi:10.1097/QAI.0b013e3181baf111
- Anderson, S. J., Cherutich, P., Kilonzo, N., Cremin, I., Fecht, D., Kimanga, D., … Hallett, T. B. (2014). Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: A modelling study. Lancet, 384(9939), 249–256. doi:10.1016/S0140-6736(14)61053-9
- Aspinall, E., Dhanya, N., & Goldberg, D. (2014). Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: A systematic review and meta-analysis. International Journal of Epidemiology, 43(1), 235–248. doi:10.1093/ije/dyt243
- Auvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J., Sitta, R., & Puren, A. (2005). Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLoS Medicine, 2(11), e298. doi:10.1371/journal.pmed.0020298
- Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., … Celum, C. (2012). Antiretroviral prophylaxis for HIV-1 prevention among heterosexual men and women. The New England Journal of Medicine, 367(5), 399–410. doi:10.1056/NEJMoa1108524
- Bailey, R. C., Moses, S., Parker, C. B., Agot, K., Maclean, I., Krieger, J. N., … Ndinya-Achola, J. O. (2007). Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet, 369(9562), 643–656. doi:10.1016/S0140-6736(07)60312-2
- Baird, S., McIntosh, C., & Özler, B. (2012). Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: A cluster randomised trial. Lancet, 379(9823), 1320–1329. doi:10.1016/S0140-6736(11)61709-1
- Björkman-Nyqvist, M., Corno, L., de Walque, D., & Svensson, J. (2013). Evaluating the impact of short term financial incentives on HIV and STI incidence among youth in Lesotho: A randomized trial. TUPDC0106 – Poster Discussion Session, 7th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, Kuala Lumpur.
- Bryden, D. (2011). Condom gap ‘quite disturbing’ according to PEPFAR. Science Speaks. HIV & TB News. A project of the Centre for Global Health Policy. Retrieved from http://sciencespeaksblog.org/2011/02/02/condom-gap-quite-disturbing-according-to-pepfar/
- Burton, J., Darbes, L., & Operario, D. (2010). Couples-focused behavioural interventions for prevention of HIV: Systematic review of the state of evidence. AIDS Behavior, 14(1), 1–10. doi:10.1007/s10461-008-9471-4
- Celum, C., Baeten, J., & Hughes, J. P. (2013). Integrated strategies for combination HIV prevention: Principles and examples for men who have sex with men in the Americas and heterosexual African populations. Journal of Acquired Immune Deficiency Syndromes, 63(Suppl. 2), S213–S220. doi:10.1097/QAI.0b013e3182986f3a
- Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., … Vanichseni, S. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 381(9883), 2083–2090. doi:10.1016/S0140-6736(13)61127-7
- Cohen, M. S., Dye, C., Fraser, C., Miller, W. C., Powers, K. A., & Williams, B. G. (2012). HIV treatment as prevention: Debate and commentary – Will early infection compromise treatment-as-prevention strategies? PLoS Medicine, 9(7), e1001232. doi:10.1371/journal.pmed.1001232
- Das, M., Chu, P. L., Santos, G.-M., Scheer, S., Vittinghoff, E., McFarland, W., & Colfax, G. N. (2010). Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE, 5(6), e11068. doi:10.1371/journal.pone.0011068
- De Cock, K. M., Gilks, C. F., Lo, Y., & Guerma, T. (2009). Can antiretroviral therapy eliminate HIV transmission? The Lancet, 373(9657), 7–9. doi:10.1016/S0140-6736
- Eaton, J. W., Johnson, L. F., Salomon, J. A., Bärnighausen, T., Bendavid, E., Bershteyn, A., … Hallett, T. B. (2012). HIV treatment as prevention: Systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Medicine, 9(7), e1001245. doi:10.1371/journal.pmed.1001245
- Eyawo, O., de Walque, D., Ford, N., Gakii, G., Lester, R. T., & Mills, E. J. (2010). HIV status in discordant couples in sub-Saharan Africa: A systematic review and meta-analysis. Lancet Infectious Diseases, 10(11), 770–777. doi:10.1016/S1473-3099(10)70189-4
- Fraser, N., Kerr, C. C., Harouna, Z., Alhousseini, Z., Cheikh, N., Gray, R., … Görgens, M. (2015). Reorienting the HIV response in Niger toward sex work interventions: From better evidence to targeted and expanded practice. Journal of Acquired Immune Deficiency Syndromes, 68(Suppl. 2), S213–S220. doi:10.1097/QAI.0000000000000456
- Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009). Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet, 373(9657), 48–57. doi:10.1016/S0140-6736(08)61697-9
- Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., … Glidden, D. V. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. Lancet Infectious Diseases, 14(9), 820–829. doi:10.1016/S1473-3099(14)70847-3
- Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. The New England Journal of Medicine, 363(27), 2587–2599. doi:10.1056/NEJMoa1011205
- Gray, R. H., Kigozi, G., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., … Wawer, M. J. (2007). Male circumcision for HIV prevention in men in Rakai, Uganda: A randomized trial. Lancet, 369(9562), 657–666. doi:10.1016/S0140-6736(07)60313-4
- Gregson, S., Gonese, E., Hallett, T. B., Taruberekera, N., Hargrove, J. W., Lopman, B., … Mugurungi, O. (2010). HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review. International Journal of Epidemiology, 39(5), 1311–1323. doi:10.1093/ije/dyq055
- Grinsztejn, B., Hosseinipour, M. C., Ribaudo, H. J., Swindells, S., Eron, J., Chen, Y. Q., … HPTN 052-ACTG Study Team. (2014). Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trial. The Lancet Infectious Diseases, 14(4), 281–290. doi:10.1016/S1473-3099(13)70692-3
- Hallett, T. B., Gregson, S., Mugurungi, O., Gonese, E., & Garnett, G. P. (2009). Assessing evidence for behaviour change affecting the course of HIV epidemics: A new mathematical modelling approach and application to data from Zimbabwe. Epidemics, 1(2), 108–17. doi:10.1016/j.epidem.2009.03.001
- Halperin, D. T., Mugurungi, O., Hallett, T. B., Muchini, B., Campbell, B., Magure, T., … Gregson, S. (2011). A surprising prevention success: Why did the HIV epidemic decline in Zimbabwe? PLoS Medicine, 8(2), e1000414. doi:10.1371/journal.pmed.1000414
- Hanenberg, R. S., Rojanapithayakorn, W., Kunasol, P., Sokal, D. C. (1994). Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet, 344(8917), 243–245. doi:10.1016/S0140-6736(94)93004-X
- Henderson, F. L., Taylor, A. W., Chirwa, L. I., Williams, T. S., Borkowf, C. B., Kasonde, M., … Samandari, T. (2015, July 18–22). Characteristics and oral PrEP adherence in the TDF2 open-label extension in Botswana. Abstract TUAC0203. Eighth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), Vancouver, Canada.
- The INSIGHT START Study Group. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV Infection. New England Journal of Medicine, 373(9), 795–807. doi:10.1056/NEJMoa1506816
- Johnson, L. F., Hallett, T. B., Rehle, T. M., & Dorrington, R. E. (2012). The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: A model-based analysis. Journal of the Royal Society Interface, 9(72), 1544–1554. doi:10.1098/rsif.2011.0826
- Kerr, C. C., Stuart, R. M., Gray, R. T., Shattock, A. J., Fraser-Hurt, N., Benedikt, C., … Wilson, D. P. (2015). Optima: A model for HIV epidemic analysis, program prioritization, and resource optimization. Journal of Acquired Immune Deficiency Syndromes, 69(3), 365–376. doi:10.1097/QAI.0000000000000605
- Korenromp, E. L., Gobet, B., Fazito, E., Lara, J., Bollinger, L., & Stover, J. (2015). Impact and cost of the HIV/AIDS National Strategic Plan for Mozambique, 2015–2019 – Projections with the spectrum/goals model. PLoS ONE, 10(11), e0142908. doi:10.1371/journal.pone.0142908
- Lecher, S., Ellenberger, D., Kim, A. A., Fonjungo, P. N., Agolory, S., Borget, M. Y., … Nkengasong, J. (2015). Scale-up of HIV viral load monitoring – Seven Sub-Saharan African Countries. MMWR. Morbidity and Mortality Weekly Report, 64(46), 1287–1290. doi:10.15585/mmwr.mm6446a3
- Levi, J., Raymond, A., Pozniak, A., Vernazza, P., Kohler, P., & Hill, A. (2015). Can the UNAIDS 90-90-90 target be reached? Abstract MOAD0102. Eighth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), Vancouver.
- Loutfy, M. R., Wu, W., Letchumanan, M., Bondy, L., Antoniou, T., Margolese, S., … Rochon, P. A. (2013). Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS ONE, 8(2), e55747. doi:10.1371/journal.pone.0055747
- MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., … Hickman, M. (2012). Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis. British Medical Journal, 345(7879), e5945. doi:10.1136/bmj.e5945
- Marks, G., Gardner, L. I., Rose, C. E., Zinski, A., Moore, R. D., Holman, S., … Giordano, T. P. (2015). Time above 1500 copies: A viral load measure for assessing transmission risk of HIV-positive patients in care. AIDS, 29(8), 947–954. doi:10.1097/QAD.0000000000000640
- Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., … for the VOICE Study Team. (2015). Tenofovir-based preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 372(6), 509–518. doi:10.1056/NEJMoa1402269
- Marzel, A., Shilaih, M., Yang, W. L., Böni, J., Yerly, S., Klimkait, T., … for the Swiss HIV Cohort Study. (2015). HIV-1 transmission during recent infection and during treatment interruptions as major drivers of new infections in the Swiss HIV cohort study. Clinical Infectious Diseases, 62(1), 115–122. doi:10.1093/cid/civ732
- McCormack, S., & Dunn, D. (2015). Pragmatic open-label randomised trial of pre-exposure prophylaxis: The PROUD study. Abstract number 22LB. Conference on retroviruses and opportunistic infections, Seattle.
- McNairy, M. L., & El-Sadr, W. M. (2014). Antiretroviral therapy for the prevention of HIV transmission: What will it take? Clinical Infectious Diseases, 58(7), 1003–1011. doi:10.1093/cid/ciu018
- Molina, J-M., Capitant, C., Spire, B., Pialoux, G., Chidiac, C., Charreau, I., … Delfraissy, J-F. (2015). On demand PrEP with oral TDF-FTC in MSM: Results of the ANRS Ipergay trial. Abstract 23B. Conference on Retroviruses and opportunistic infections, Seattle.
- Montaner, J. S. G., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., … Kendall, P. (2010). Expanded HAART coverage is associated with decreased population-level HIV-1-RNA and annual new HIV diagnoses in British Columbia, Canada. Lancet, 376(9740), 532–539. doi:10.1016/S0140-6736(10)60936-1
- Nachega, J. B., Uthman, O. A., Mills, E. J., & Quinn, T. C. (2013). Adherence to antiretroviral therapy for the success of emerging interventions to prevent HIV transmission: A wake up call. Journal of AIDS & Clinical Research, 01(Suppl. 4), 007. doi:10.4172/2155-6113.S4-007
- Pettifor, A., MacPhail, C., Selin, A., & Gomez-Olivé, X. (2015). HPTN 068 conditional cash transfer to prevent HIV infection among young women in South Africa: Results of a randomized controlled trial. Abstract. 8th International AIDS Society Conference on HIV pathogenesis, treatment and prevention, Vancouver. Retrieved from http://pag.ias2015.org/Search/Index
- Phillips, A. N., Cambiano, V., Nakagawa, F., Brown, A. E., Lampe, F., Rodger, A., … Delpech, V. C. (2013). Increased HIV incidence in men who have sex with men despite high levels of art-induced viral suppression: Analysis of an extensively documented epidemic. PLoS ONE, 8(2), e55312. doi:10.1371/journal.pone.0055312
- Ramanathan, S., Deshpande, S., Gautam, A., Pardeshi, D. B., Ramakrishnan, L., Goswami, P., … Mainkar, M. M. (2014). Increase in condom use and decline in prevalence of sexually transmitted infections among high-risk men who have sex with men and transgender persons in Maharashtra, India: Avahan, the India AIDS Initiative. BMC Public Health, 14(1), 784. doi:10.1186/1471-2458-14-784
- Rees, H., Delany-Moretlwe, S., Lombard, C., Baron, D., Panchia, R., Myer, L., … Gray, G. (2015, February 23–26). FACTS 001 phase III trial of pericoital tenofovir 1% gel for HIV prevention in women. Abstract number: Conference on retroviruses and opportunistic infections, Seattle.
- Rosen, S., & Fox, M. P. (2011). Retention in HIV care between testing and treatment in sub-Saharan Africa: A systematic review. PLoS Medicine, 8(7), e1001056. doi:10.1371/journal.pmed.1001056
- Sandøy, I. F., Blystad, A., Shayo, E. H., Makundi, E., Michelo, C., Zulu, J., & Byskov, J. (2012). Condom availability in high risk places and condom use: A study at district level in Kenya, Tanzania and Zambia. BMC Public Health, 12(1), 1030. doi:10.1186/1471-2458-12-1030.
- Scott-Sheldon, L., Huedo-Medina, T., & Warren, M. (2011). Behavioral interventions to increase condom use and reduce sexually transmitted infections: A meta-analysis, 1991 to 2010. Journal of Acquired Immune Deficiency Syndromes, 58(5), 489–498. doi:10.1097/QAI.0b013e31823554d7
- Severe, P., Juste, M. A. J., Ambroise, A., Eliacin, L., Marchand, C., Apollon, S., … Fitzgerald, D. W. (2010). Early versus standard antiretroviral therapy for HIV infected adults in Haiti. The New England Journal of Medicine, 363(3), 257–265. doi:10.1056/NEJMoa0910370
- Shelton, J. D. (2011). HIV/AIDS. ARVs as HIV prevention: A tough road to wide impact. Science, 334(6063), 1645–1646. doi:10.1126/science.1212353
- Shisana, O., Rehle, T., Simbayi, L. C., Zuma, K., Jooste, S., Zungu, N., … Onoya, D. (2014). South African national HIV prevalence, incidence and behaviour survey, 2012. Retrieved from http://www.hsrc.ac.za/uploads/pageContent/4565/SABSSM%20IV%20LEO%20final.pdf
- Siedner, M. J., Ng, C. K., Bassett, I. V., Katz, I. T., Bangsberg, D. R., & Tsai, A. C. (2015). Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002–2013: A meta-analysis. Clinical Infectious Diseases, 60(7), 1120–1127. doi:10.1093/cid/ciu1137
- Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, C. A. (2010). HIV and risk environment for injecting drug users: The past, present, and future. Lancet, 376(9737), 268–284. doi:10.1016/S0140-6736(10)60743-X
- Sudarshi, D., Pao, D., Murphy, G., Parry, J., Dean, G., & Fisher, M. (2008). Missed opportunities for diagnosing primary HIV infection. Sexually Transmitted Infections, 84(1), 14–16. doi:10.1136/sti.2007.026963
- Tanser, F., Bärnighausen, T., Grapsa, E., Zaidi, J., & Newell, M.-L. (2013). High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science, 339(6122), 966–971. doi:10.1126/science.1228160
- The TEMPRANO ANRS 12136 Study Group. (2015). A trial of early antiretrovirals and isoniazid preventive therapy in Africa. New England Journal of Medicine, 373(9), 808–822. doi:10.1056/NEJMoa1507198
- UNAIDS & United Nations Population Fund. (2004). Making condoms work for HIV prevention. UNAIDS Best practice collection. Geneva: Author.
- UNAIDS. (2010). Young people are leading the HIV prevention revolution. Geneva: Author. Retrieved from http://www.unaids.org/sites/default/files/media_asset/20100713_outlook_youngpeople_en_0.pdf
- UNAIDS. (2013). Global report on the AIDS epidemic. Geneva: Author. Retrieved from http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf
- UNAIDS. (2014a). 90-90-90: An ambitious treatment target to end the AIDS epidemic. Geneva: Author. Retrieved from http://www.unaids.org/en/resources/documents/2014/90-90-90
- UNAIDS. (2014b). Fast-track. Ending the AIDS epidemic by 2030. Geneva: Author. Retrieved from http://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf
- UNAIDS. (2015a). How AIDS changed everything. MDGs, 15 years, 15 lessons of hope from the AIDS response. Geneva: Author. Retrieved from http://www.unaids.org/sites/default/files/media_asset/MDG6Report_en.pdf
- UNAIDS. (2015b). Global AIDS response progress reporting. Geneva: Author.
- UNAIDS. (2015c). HIV estimates with uncertainty bounds 1990–2014. Updated 12 August 2015. Released with: How AIDS changed everything. Geneva: Author.
- UNAIDS. (2015d). Invest in HIV prevention. Quarter for HIV prevention. Geneva: Author.
- UNAIDS. (2015e). World AIDS day report 2015. Geneva: Author.
- United Nations Population Fund. (2013). Donor Support for contraceptives and condoms for family planning and STI/HIV prevention in 2012. Final draft. New York, NY: Author.
- United Nations Population Fund. (2014). Contraceptives and condoms for Family Planning and STI/HIV prevention. External Procurement support reports 1997, 2005, 2007, 2008, 2009, 2010, 2012, 2013. New York, NY: Author.
- United States President’s Emergency Plan for AIDS Relief. (2013). PEPFAR’s best practice for voluntary medical male circumcision site operations. Washington, DC: Author. Retrieved from https://www.usaid.gov/sites/default/files/documents/1864/pepfar_best_practice_for_vmmc_site_operations.pdf
- Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., … for the FEM-PrEP Study Group, D. (2012). Preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 367(5), 411–422. doi:10.1056/NEJMoa1202614
- Vermund, S. H., Sidat, M., Weil, L. F., Tique, J. A., Moon, T. D., & Ciampa, P. J. (2012). Transitioning HIV care and treatment programs in southern Africa to full local management. AIDS, 26(10), 1303–1310. doi:10.1097/QAD.0b013e3283552185
- Wagenaar, B. H., Gimbel, S., Hoek, R., Pfeiffer, J., Michel, C., Manuel, J. L., … Sherr, K. (2014). Stock-outs of essential health products in Mozambique-longitudinal analyses from 2011 to 2013. Tropical Medicine & International Health, 19(7), 791–801. doi:10.1111/tmi.12314
- Williams, J. R., Alary, M., Lowndes, C. M., Béhanzin, L., Labbé, A.-C., Anagonou, S., … Boily, M.-C. (2014). Positive impact of increases in condom use among female sex workers and clients in a medium HIV prevalence epidemic: Modelling results from project SIDA1/2/3 in Cotonou, Benin. PLoS ONE, 9(7), e102643. doi:10.1371/journal.pone.0102643
- Wondergem, P., Green, K., Wambugu, S., Asamoah-Adu, C., Clement, N. F., Amenyah, R., … Szpir, M. (2015). A short history of HIV prevention programs for female sex workers in Ghana: Lessons learned over 3 decades. Journal of Acquired Immune Deficiency Syndromes, 68(Suppl. 2), S138–S145. doi:10.1097/QAI.0000000000000446
- World Bank, University of New South Wales. (2014). Sudan’s HIV response: Value for money in a low-level HIV epidemic. Findings from the HIV allocative efficiency study. Washington, DC: Author. Retrieved from http://www.optimamodel.com/pubs/sudan-report.pdf
- World Bank, University of New South Wales. (2015). Zambia’s HIV response: Prioritised and strategic allocation of HIV resources for impact and sustainability. Findings from the HIV allocative efficiency study. Washington, DC: Author. Retrieved from http://optimamodel.com/pubs/zambia-report.pdf
- World Health Organization & UNAIDS. (2011). Joint strategic action framework to accelerate the scale-up of voluntary medical male circumcision for HIV prevention in Eastern and Southern Africa. Geneva: Author.
- World Health Organization. (2012). Guidance on couples HIV testing and counselling – Including antiretroviral therapy for treatment and prevention in serodiscordant couples – Recommendations for a public health approach. Geneva: Author.
- World Health Organization. (2013). Consolidated guidelines for the use of art for prevention and treatment. Geneva: Author.
- World Health Organization. (2014). Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. Geneva: Author.
- World Health Organization. (2015a). Global health sector response to HIV, 2000-2015: Focus on innovations in Africa: Progress report. Geneva: Author.
- World Health Organization. (2015b). Progress brief. Voluntary medical male circumcision for HIV prevention in 14 priority countries in East and Southern Africa. Geneva: Author.
- World Health Organization. (2015c). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: Author.